JoVE Logo

Sign In

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

18.1K Views

10:49 min

September 18th, 2013

DOI :

10.3791/50720-v

September 18th, 2013


Transcript

Explore More Videos

Keywords Tyrosine Kinase Inhibitors

Chapters in this video

0:05

Title

1:39

Phospho-protein Western Blot

3:02

Methylcellulose Assay

4:24

Evaluation of Phospho-protein Inhibition in vivo

5:39

Evaluation of Anti-leukemia Activity of TKIs in ALL Xenograft Models

8:13

Results: Biochemical and Functional Effects Mediated by TKIs

10:07

Conclusion

Related Videos

article

08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

20.0K Views

article

09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

8.2K Views

article

07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

7.9K Views

article

10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

8.2K Views

article

11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

11.0K Views

article

13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

7.8K Views

article

14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

3.2K Views

article

06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

1.3K Views

article

09:20

Rapid In Vitro Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging

2.1K Views

article

12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

14.8K Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved